John Ballantyne
North America, North Dakota, United States, Fargo
Description
John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Of...
Investor Profile
John Ballantyne has made 10 investments, with 4 in the past 12 months and 50% as lead.
Stage Focus
- Seed (30%)
- Series A (20%)
- Series Unknown (20%)
- Series B (10%)
- Angel (10%)
- Post Ipo Equity (10%)
Country Focus
- United States (90%)
- Singapore (10%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Life Science
- Genetics
- Medical
- Oncology
- Pet
- Veterinary
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.